Staphysagria Pellet
FDA Label NDC 15631-0413

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc for the product Staphysagria (NDC 15631-0413). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, uses, indications, dosage, warnings, otc - stop use, otc - pregnancy or breast feeding, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient

STAPHYSAGRIA HPUS 3X and higher

Uses

Styes, Warts, Eczema

Indications

Condition listed above or as directed by the physician

Dosage

Adults- Take 4 or 6 Pellets by mouth, three times daily or as suggested by physician. Children 2 years and older- take 1/2 the adult dose.

Warnings

This product is to be used for self-limiting conditions

Otc - Stop Use

If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional

Otc - Pregnancy Or Breast Feeding

As with any drug, if you are preganant, or nursing a baby, seek professional advice before taking this product

Otc - Keep Out Of Reach Of Children

Keep this and all medication out of reach of children

Otc - Do Not Use

Do not use if capseal is broken or missing.

Close the cap tightly after use.

Inactive Ingredients

Sucrose

Storage

Store in a cool dark place

* Please review the disclaimer below.